Howe & Rusling Inc Concert Pharmaceuticals, Inc. Transaction History

Howe & Rusling Inc

  • $1.16 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Jul 31, 2018
SELL
$16.83 - $21.66 $925 - $1,191
-55 Closed
0 $0
Q1 2018

May 14, 2018
BUY
$19.24 - $28.03 $288 - $420
15 Added 37.5%
55 $1,000
Q4 2017

Jan 24, 2018
BUY
$13.96 - $29.05 $558 - $1,162
40
40 $1,000

Others Institutions Holding CNCE

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About CONCERT PHARMACEUTICALS, INC.

CNCE Quotes by TradingView
  • Ticker CNCE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,934,600
  • Description
  • Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...
More about CNCE
Track This Portfolio

Track Howe & Rusling Inc Portfolio

Follow Howe & Rusling Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Howe & Rusling Inc, based on Form 13F filings with the SEC.

News

Stay updated on Howe & Rusling Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email